AndhraNews.net
Home » Features » Health » Paralysis

Paralysis


About Paralysis

Paralysis in News

Retired U.S. Senator Tom Harkin Joins Masimo’s Board of Directors
Business Wire IndiaMasimo (NASDAQ: MASI), a global innovator of noninvasive patient monitoring technologies, announced today that retired Senator Tom Harkin, former five-term U.S. Senator and former Chairman of the Senate Health, Education, Labor and Pension (HELP) Committee, has been elected to Masimo’s Board of Directors.

Taro Provides Results for September 30, 2015
Business Wire IndiaTaro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) provided unaudited financial results for the three and six months ended September 30, 2015.

Taro’s Keveyis™ (dichlorphenamide) 50 mg Tablets Now Available for the Treatment of Primary Hyperkalemic and Hypokalemic Periodic Paralysis
Business Wire IndiaTaro Pharmaceutical Industries Ltd. (NYSE:TARO) announced that Keveyis™ (dichlorphenamide) 50 mg Tablets, the first medicine approved by the U.S

FDA Approves Taro’s Keveyis™ (dichlorphenamide) 50 mg Tablets for Primary Hyperkalemic and Hypokalemic Periodic Paralysis
Business Wire IndiaTaro Pharmaceutical Industries Ltd. (NYSE:TARO) announced that the U.S. Food and Drug Administration (FDA) has approved Keveyis™ (dichlorphenamide) 50 mg Tablets for the treatment of primary hyperkalemic and hypokalemic periodic paralysis, a group of rare hereditary disorders that cause episodes of muscle weakness or paralysis [1]

Urban Planning Key to the Success of Smart Cities
Business Wire India"The announcement of the launch of 100 smart cities is a welcome initiative that will boost growth in the future. This is the first important step towards dealing with an old problem that has only worsened with time- urban planning. Urbanization in India has been a victim of systemic inefficiencies and policy paralysis

Relief India Trust's Success Story of a Recovering Disabled
Business Wire IndiaRelief India Trust’s recent achievement attributes to the successful treatment of a paralytic patient, five-year old Baby Laavi. Belonging to a family of lower income strata, Baby Laavi met with a serious accident and fell down from stairs at the age of 2. She incurred severe injuries to her head and paralysis of the entire left part of her body

Curb Energy Consumption
(Family Features) Water heaters are energy intensive appliances. In fact, they are the second largest energy user in the home, and as they age, they become less efficient, requiring even more energy.

Abacus Data Systems Announces Strategic Investment by Providence Equity to Fuel Growth and Innovation
SAN DIEGO, CA--(Marketwired - December 16, 2015) - Abacus Data Systems, Inc. (Abacus), the leading provider of Single Source Fully Managed Technology Solutions (est. 1983), today announced a strategic majority investment by Providence Equity, a leading global private equity firm.

Pittsburgh Facial Plastic Surgeon Appears on KDKA-TV to Perform a KYBELLA Double Chin Reduction Treatment
The accumulation of excess fat under the chin is a common condition that can even be experienced by people who are in the best possible shape. Dr. Paul Leong, a facial plastic surgeon in Pittsburgh, says the most effective way to eliminate the appearance of a "double chin" caused by excess fat has traditionally been liposuction... but that may be changing

NCCN Collaborates With Bristol-Myers Squibb to Study PD-L1 Expression and Test Interpretation in Lung Cancer
FORT WASHINGTON, PA--(Marketwired - November 30, 2015) - New molecules and pathways with pivotal functions in regulating the immune system have been discovered recently, providing new understanding of how tumor cells avoid the immune system

Fish & Richardson Principal Michael Hamlin Named a National Law Journal "Boston Rising Star"
Fish & Richardson announced today that Michael Hamlin, a principal in the firm's Boston office, has been named a "Boston Rising Star" by the National Law Journal (NLJ). According to the NLJ, the Rising Stars "stand out as new leaders in the legal profession

OCTANe Set to Host 10th Annual Medical Device & Investor Forum
OCTANe, the Orange County business development accelerator dedicated to driving technology industry growth and innovation by connecting ideas and people with resources and capital, today announced the final agenda for its 10th Annual Medical Device & Investor Forum (MDIF) taking place November 2-3, 2015.

Pilot Flying J Announces 2015 Road Warrior(R) Grand Prize Winner
KNOXVILLE, TN--(Marketwired - October 22, 2015) - Pilot Flying J, the largest operator of travel centers in North America, today named Oceanside, California resident Erik Michaels its 2015 Road Warrior® grand prize winner

Research Reveals Fear of Failure Has Us All Shaking in Our Boots This Halloween
Forget about slasher movies, haunted houses or things that go bump in the night; the latest research from goal-based social network, Linkagoal, reveals what is really making us shake in our boots this Halloween season -- failure.

Organizers Forced to Cancel This Weekend's Bike MS: City to Shore Ride
NJ Governor Chris Christie has signed an executive order declaring a State of Emergency, forcing the cancellation of the 2015 Bike MS: City to Shore Ride.

FeeX Launches 401k Rollover Center to Show Investors What to Do With Old 401ks
FeeX, a free service that helps investors see and understand fees in their investment and retirement accounts, today unveiled its new 401k Rollover Center

TissueGen Appoints Dr. Jennifer Seifert as Senior Scientist to Lead Spinal Cord Injury Repair Program
TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, today announced that Jennifer Seifert, Ph.D., has joined the company in the newly established role of Senior Scientist. Seifert will lead TissueGen's application of ELUTE fiber technology to treat spinal cord injuries and related applications for regenerative medicine.

Paralyzed Veterans Promotes Adaptive Sports and Recreation Opportunities to Encourage Injured Veterans to Be More Active and Healthy
As a leader in the development of adaptive sports and recreation programs, Paralyzed Veterans of America (Paralyzed Veterans) has been dedicated to helping our injured veterans rebuild their lives and accomplish their goals by engaging in adaptive sports activities.

Thousands Will Walk to Create a World Free of MS This Spring at Walk MS at Locations All Over the Greater Delaware Valley
Over 12,000 people are expected to raise more than $2 million to support cutting-edge research and life-changing programs and services for people living with MS at Walk MS 2015, hosted by the Greater Delaware Valley Chapter of the National Multiple Sclerosis Society

Not an April Fool's Joke: Netwrix Empowers the Cyber Security of Small Businesses for Free
Netwrix Corporation, the #1 provider of change and configuration auditing software, announced today that Netwrix Auditor for Active Directory will be available for free to small businesses with no more than 100 user accounts if downloaded during April 2015

Anapol Schwartz Attorneys Obtain $1.5 Million Settlement for Woman Injured From a Flu Vaccine
Anapol Schwartz attorneys Lawrence Cohan and David Carney obtained a $1.5 million settlement on behalf of a Lebanon, PA woman who developed life-altering complications from Guillain-Barré Syndrome (GBS) and severe ataxia after receiving an influenza (flu) vaccine.

Flamel Technologies Announces Positive Results of a Second Clinical Trial With Micropump(R) Sodium Oxybate
Flamel Technologies (NASDAQ: FLML) today announced that its second clinical study in healthy volunteers using its proprietary Micropump® technology applied to sodium oxybate has achieved the objective of one single dose before bedtime for patients suffering from narcolepsy, confirming the results of a previous, first-in-man, study

SEB: Nordic Outlook: Increased stress squeezing global growth - Riksbank looking inside its unconventional toolkit
The world economy's big headache is the shortage of optimism. Economic policy instruments are becoming fewer and fewer, as well as less effective, but the toolkit is not yet empty. Global growth in 2015-2016 will enjoy support from continued monetary expansion and an increasingly solid recovery in the United States

Regenerative Neurobiology Experts' Session at Neuroscience 2014 Demonstrates TissueGen's Approach to Nerve Repair
TissueGen® Inc., developer of a groundbreaking biodegradable fiber format for drug delivery, today announced that they will be attending the Society for Neuroscience's annual meeting, Neuroscience 2014. TissueGen will be present for the poster presentation by regenerative neurobiology experts from the University of Texas at Dallas. This research team, led by Dr

NFL Grant Enables University of Miami, University of Pittsburgh & Neuro Kinetics to Study New Diagnostic Device for Early & Accurate Detection of Concussions
A $500,000 grant from the National Football League (NFL) will enable the University of Miami Miller School of Medicine, the University of Pittsburgh Medical School and medical equipment manufacturer Neuro Kinetics Inc. (NKI) to test NKI's I-Portal® PAS, a diagnostic device for early and accurate detection of concussions.

Parker Indego Now at Kessler Foundation in West Orange, NJ
Robotics researchers at Kessler Foundation are broadening their investigation of the application of exoskeletal devices for rehabilitation and community use. Kessler Foundation is one of five leading rehabilitation research centers within the United States to receive Indego -- a powered lower limb orthosis, also known as an exoskeleton -- as part of a new national multicenter study

Cancer Patients With Malignant Spinal Cord Compression Experienced Preserved Mobility When Administered One High-Dose of Radiation Therapy

Kessler Foundation Expands Robotic Research in Spinal Cord Injury
Kessler Foundation has expanded its research in exoskeletal-assisted standing and walking with the addition of ReWalk, the robotic exoskeleton from ReWalk Robotics. The Foundation has been conducting exoskeletal research since October 2011, according to Gail Forrest, PT, PhD, assistant director of Human Performance & Engineering Research.

Innovation Roadblocks Plague Companies, but the Problem Has Little to Do With Ideas or Funding, Executives Say in Survey
Executives voice significant concerns about their companies' ability to innovate to meet the demands of the future -- and they say the problem is not a lack of good ideas or money, but figuring out how to put them to work. That's according to a new survey of 800 executives in 20 industries by strategy and innovation consulting firm Innosight.

17th Annual Wacky Warning Labels(TM) Contest: 2014 Finalists Selected
WASHINGTON, DC--(Marketwired - July 01, 2014) - The internationally recognized Wacky Warning Labels™ Contest, now in its 17th year, has selected the 2014 FINALISTS! The top five finalists are:

ESFI Warns About the Dangers of Electric Shock Drowning This Fourth of July
ARLINGTON, VA--(Marketwired - June 30, 2014) - The Fourth of July holiday is not only one of the most popular boating days of the season, but it is also the deadliest. According to the U.S. Coast Guard, the Fourth of July, combined with Memorial Day and Labor Day, typically account for more than one third of all boating-related accidents and fatalities.

Cytokinetics Announces Three Publications Relating to Tirasemtiv and the Impact of Skeletal Muscle Activation on Respiratory Function and Muscle Strength
Manuscripts Support Rationale for Potential Further Development of Tirasemtiv in Patients Living with ALS

Ben Affleck, Award-Winning Director, Producer and Actor, Joins Paralyzed Veterans of America in Helping to Support and Honor Our Nation's Injured Veterans
Ben Affleck, known around the world for his award-winning work as a film director, producer, actor and writer, is appearing in a new television and radio public service announcement (PSA) for Paralyzed Veterans of America (Paralyzed Veterans).

Obsession With the Mythical "Perfect Idea" Is the Downfall of Most Innovation Efforts
When trying to get their ideas off the drawing board and into the market, most innovators spend too much time, energy and money using the wrong toolkit to solve the wrong problem. They try to come up with a "perfect idea" that will disrupt the market or change the world

John "Jack" Schneider, Former Managing Director of Allen & Co. Joins Envision Solar International Board of Directors
SAN DIEGO, CA--(Marketwired - April 10, 2014) - Envision Solar International, Inc., (OTCQB: EVSI) a leading renewable energy media and branding product company, today announced the addition of Jack Schneider, formerly Managing Director of Allen & Co. LLC, to its Board of Directors.

Ekso Bionics CEO Nathan Harding to Be Interviewed Live Today on Clear Channel Business Talk Radio
Ekso Bionics Holdings, Inc. (OTCQB: EKSO), a robotic exoskeleton pioneer, today announced that CEO Nathan Harding will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. Any interested parties may tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.

Zumba & Augie Nieto Launch Global Campaign to Help Find a Cure for Lou Gehrig's Disease
TUCSON, AZ--(Marketwired - March 18, 2014) - The Muscular Dystrophy Association (MDA) and global fitness brand Zumba have teamed up to launch the campaign, "Together We Dance

India’s Path to High Economic Growth is Achievable by the end of 2020, says Frost & Sullivan
Frost & Sullivan presents a brief survey of the Indian Economy, its passage through 2014. From a policy perspective, the year 2014 can be divided into two distinctive phases demarcated by the change of guard at the Center in May-end

Panasonic's Robotic Technology Helps Deliver ""A Better Life"" to the World of Welfare
Panasonic Corporation is taking part in the 41st Home Care and Rehabilitation Exhibition, H.C.R. 2014, which is being held at the Tokyo Big Sight from October 1 to 3, 2014.

PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis
Biogen Idec (NASDAQ: BIIB) has announced that the European Commission (EC) has granted marketing authorization for PLEGRIDYTM (peginterferon beta-1a) as a treatment for adults with relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS)

Historic 6th Annual Pharmaceutical Leadership Summit and Pharmaleaders Awards 2013 Focused to Give Aam Admi of India Affordable Medicines and Quality Healthcare
In a sequel to the sixty days of the voting by the Indian masses to select the best of the best in the final five nominees in various important categories & individual nonvoting categories, Pharmaleaders (www.pharmaleaders

Noted Healthcare Industry Experts and Medical Professionals to Receive Pharmaleaders 2013 Power Brand Awards
In an era where Healthcare in India is the most neglected as Politicians & Policy Makers are busy scoring their political points, Pharmaleaders attempt to raise the uncomfortable questions ignored by other media houses as we believe that healthcare is key to the nation development & India cannot be a mute spectator where policy reforms in healthcare has taken a backstage over political issues

Wolters Kluwer (CCH India) hosts Mergers and Acquisitions Conclave
More than 50 delegates from the corporate, consulting and legal community attended the CCH India Mergers and Acquisitions (M&A) conclave on July 4 and 5, 2013 at Hotel Sahara Star in Mumbai. The conclave was backed by Ernst & Young LLP as Knowledge Partners and Nishith Desai Associates as Legal Partners and focused on the current M&A challenges, opportunities and goals

American Traffic Solutions Finds Driver Behavior Changing at St. Louis' Red-Light Safety Camera Monitored Intersections
ST. LOUIS, MO--(Marketwired - November 05, 2013) - Driver behavior at St. Louis red-light safety cameras monitored intersections continues to change according to a recent analysis by American Traffic Solutions (ATS)

NuPathe Announces Allowance of Additional U.S. Patent for ZECUITY
NuPathe Inc. (NASDAQ: PATH) today announced that the United States Patent and Trademark Office has issued a notice of allowance for U.S. Patent application 13/407,434. This application relates to NuPathe's innovative iontophoretic patch that uses a two-stage delivery sequence to transdermally deliver sumatriptan

NuPathe Announces Third Quarter 2013 Financial Results and Recent Operational Highlights
NuPathe Inc. (NASDAQ: PATH) today announced financial results for the quarter ended September 30, 2013, as well as recent operational highlights.

IntelliCell Biosciences Stem Cells Used to Successfully Treat Bell's Palsy and Type I Diabetes Patient
IntelliCell Biosciences, Inc. (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels, announced today that it has supplied its cellular product, stromal vascular fraction cells ("SVFC"), to Regen Medical PC for the successful treatment of a Type I diabetic patient, who had developed bilateral permanent Bell's palsy.

Bouncing Back -- an Autobiography by Bill Bartmann
"Some people have made more money than I have, though it's fewer than the number of Olympic Gold Medals ever awarded... I cannot think of anyone who's been to both extremes in quite the way I have. The poverty, pigs, paralysis, and prosecutors at one end of the spectrum - and the family, fortune, and endless frontiers at the other

NuPathe Doses Adolescent Migraineurs in Clinical Study of ZECUITY
NuPathe Inc. (NASDAQ: PATH) today announced the Company has initiated dosing of patients for NP101-015, a Phase 1 study of ZECUITY® (sumatriptan iontophoretic transdermal system) in adolescents with a history of migraine attacks. This open label, single-dose study will assess the safety, pharmacokinetics, and tolerability of ZECUITY in adolescent migraine patients

Aeolus' AEOL 10150 Subject of $4.3 Million US Government Award for Protection Against Nerve Agents; Data Shows Drug Significantly Improves Survival in Animals Following Exposure to Pilocarpine, a Nerve Agent Surrogate for Soman and Sarin Gas
Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)

SEB: Nordic Outlook: US holds the key to economic recovery
Low inflation will delay Riksbank's key interest rate hikes

BMO Harris Bank Congratulates Justine Fedak
Justine Fedak, Senior Vice President and Head of Brand, Advertising and Sponsorships for BMO Financial Group, North America is being honored today by the National MS Society as their 2013 Woman on the Move

NuPathe Announces Second Quarter 2013 Financial Results and Recent Operational Highlights
NuPathe Inc. (NASDAQ: PATH) today announced financial results for the quarter ended June 30, 2013, as well as recent operational highlights.

FDA expands age indication for Menveo®, first and only quadrivalent meningococcal vaccine for infants as young as 2 months of age[1]
Novartis International AG /FDA expands age indication for Menveo®, first and only quadrivalent meningococcal vaccine for infants as young as 2 months of age[1] . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Disciplined Growth Investors: Dangerous Competitive Advantage Myths
When analyzing stocks, not everything that looks like a competitive advantage and acts like a competitive advantage actually is a sustainable competitive advantage, according to author Frederick K. Martin of Disciplined Growth Investors.

NuPathe to Present ZECUITY Data at the 2013 International Headache Congress
NuPathe Inc. (NASDAQ: PATH) today announced the Company will present data on ZECUITY® (sumatriptan iontophoretic transdermal system) at the upcoming International Headache Congress (IHC) 2013, which takes place June 27 to 30 in Boston, MA.

Knoxville Surgeon Reveals Which Supplements Are Vital to Post-Bariatric Surgery Health
Dr. Stephen Boyce is a weight loss surgeon who has created a multivitamin specifically tailored for the needs of the pre and post-bariatric surgery patient. Patients who undergo weight loss surgery procedures like the Lap-Band® can develop serious nutritional deficiencies, particularly in the months immediately following their surgery. With over 20 years of bariatric surgery experience, Dr

Benefits of Pradaxa® maintained in difficult to treat patients with atrial fibrillation and symptomatic heart failure
For media outside of the US, the UK & Canada only

New long-term data reinforce safety profile of Pradaxa® for stroke prevention in AF
For media outside of the US, the UK & Canada only

New European survey highlights ischaemic stroke protection as treatment priority for patients with atrial fibrillation
Not intended for media in the UK, the US or Canada

Maritime Lawyers Successfully Resolve Limitation of Liability Action
Maritime lawyers Lipcon, Margulies, Alsina & Winkleman are pleased to announce that they have successfully resolved another limitation of liability proceeding in favor of their injured client. The case involved a passenger aboard a rented motorboat who was injured due to the alleged negligence of the boat club that rented the boat and the operator of the boat

Sarepta Therapeutics Announces a Continued Benefit on Walking Test Through 62 Weeks in Phase IIb Open-Label Extension Study of Eteplirsen in Duchenne Muscular Dystrophy
Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today announced updated data from Study 202, its open-label, Phase IIb extension study of eteplirsen for the treatment of Duchenne muscular dystrophy (DMD)

Stem Cell Media Interview With Dr. Adrian Harel: Fighting to End ALS, Once and for All
Sai Rosen of www.InvestorStemCell.com (Stem Cell Media, LLC) recently sat down with Dr. Adrian Harel, Chief Executive Officer for Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI). Brainstorm Cell Therapeutics Inc

Clarity's New Fortissimo(TM) Voice-Activated Speakerphone Now for Sale
The 19 million Americans with mobility challenges now have a phone designed precisely for their needs. Fortissimo -- a voice-activated and hands-free speakerphone from Clarity, a division of Plantronics (NYSE: PLT) -- is now available for purchase at clarityproducts.com for $550.

Sarepta Therapeutics Enters Into Collaboration for the Development of Additional Exon-Skipping Product for Duchenne Muscular Dystrophy
Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today a collaboration for the development of an additional exon-skipping drug targeting exon 53, its fourth drug in development, in support of Sarepta's broad-based program for the treatment of Duchenne muscular dystrophy (DMD)

Sarepta Therapeutics to Present Additional 48-Week Data From the Phase IIb Study of Eteplirsen for the Treatment of Duchenne Muscular Dystrophy at the 17th Annual International World Muscle Society
Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that data from a Phase IIb study evaluating eteplirsen, an investigational treatment for boys with Duchenne muscular dystrophy (DMD), will be presented Saturday, October 13th at the World Muscle Society in Perth, Australia. Principal investigator, Jerry R. Mendell, M.D

Bal Harbour Shops' "Too Good to Keep Silent" Auction Preview Party Will Have Everyone Bidding for Coveted Items in Advance of November 10th Destination Fashion Fundraiser
Dazzling, alluring, elegant and beguiling: Those are just some of the words that can be used to describe the more than 60 auction lots -- valued at more than $300,000 -- donated by Bal Harbour Shops' generous fashion and jewelry brands for one of the most anticipated events of the year -- Destination Fashion. All of the proceeds will benefit The Buoniconti Fund to Cure Paralysis.

Fight Back Against Behemoth Annihilation in Glu Mobile's Death Dome
Fight Back Against Behemoth Annihilation in Glu Mobile's Death DomeExplore the dark depths of a city overrun by a rampant virus in Glu's highest production value game to dateSan Francisco, Calif. - Oct. 11, 2012 - Glu Mobile Inc

Sarepta Therapeutics Announces Eteplirsen Meets Primary Endpoint of Increased Novel Dystrophin and Achieves Significant Clinical Benefit on 6-Minute Walk Test After 48 Weeks of Treatment in Phase IIb Study in Duchenne Muscular Dystrophy

Addex mGluR4 Allosteric Modulator Effective in Multiple Sclerosis Model - A Novel Oral Small Molecule Approach for the Treatment of Multiple Sclerosis
Addex Therapeutics / Addex mGluR4 AllostericModulator Effective in Multiple Sclerosis Model - ANovel Oral Small Molecule Approach for the Treatment of Multiple Sclerosis.

PropThink: STEM Gains on Anticipation of Interim Trial Data to be Presented Monday
Stem Cells Inc, (NASDAQ:STEM), developer of stem cell-based treatments for spinal injury, is up for the second day in a row Friday in pre-market trading, after it closed Thursday at $1.96, a 19% gain on the day. The gains came after the company announced that it will be presenting data from its Phase I/II clinical trial on Monday, Sept

Sarepta Therapeutics Announces Significant Clinical Benefit With Eteplirsen After 36 Weeks in Phase IIb Study for the Treatment of Duchenne Muscular Dystrophy
Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today announced that treatment with its exon-skipping compound, eteplirsen, achieved a significant clinical benefit on the primary clinical outcome, the 6-minute walk test (6MWT), over a placebo/delayed treatment cohort in a Phase IIb trial in Duchenne muscular dystrophy (DMD) patients

Matthew Reeve Flies Down Under for Spinal Cord Injury Research: Continues Superman's Legacy
The late actor Christopher Reeve's son, Matthew Reeve, will make a Keynote Address at the upcoming Connections 2012 conference held by the Spinal Cord Injury Network at Sydney's Convention and Exhibition Centre on 13th August 2012.

Midas Letter's James West on the Global Debt Crisis: Here Comes the Hyper-inflationary Bailout Endgame

RELY-ABLE®: Unprecedented long-term data support safety profile and sustained efficacy of Pradaxa® for stroke prevention in AF
For Non-US, Non-UK & Non-Canadian Media Only

UPA is responsible for economic paralysis in country, alleges BJP
The Bharatiya Janata Party (BJP) has blamed the Congress-led UPA Government at the Centre for failure to prevent economic slowdown in the country.

BJP leaders, activists court arrest over UPA's inflationary policies (Update)
Scores of Bharatiya Janata Party (BJP) party workers, led by their leaders, courted arrest across the country on Friday in protest against the rising prices of essential commodities.

BJP slams UPA over failure to boost economic investment
The Bharatiya Janata Party (BJP) on Wednesday took potshots at the Congress-led UPA Government at the Centre for its failure to boost economic investment in the country.

BJP says inner contradictions within Congress responsible for policy paralysis
The Bharatiya Janata Party (BJP) on Tuesday said the global agency Standard and Poor's threat to downgrade India's credit rating is a serious matter, and blamed the inner contradictions within the Congress for the current policy paralysis.

New surgical technique may reverse hand paralysis after spinal cord injury
A UC San Diego neurosurgeon and his team have pioneered a novel technique to restore hand function in patients with spinal cord injury.

Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on InVivo Therapeutics Holdings Corp.
Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO®) on InVivo Therapeutics Holdings Corp. (OTCBB: NVIV). The full 56-page report can be found at www.crystalra.com.

Jason Mraz Launches Jason Mraz Foundation With Intimate Hometown Benefit Concert; Sold Out Performance Slated for Tomorrow at the Famed Belly Up Tavern in Solana Beach, California; Foundation Established to Support Organizations Devoted to Human Equality, Environment Preservation, Arts & Educati
Atlantic recording artist Jason Mraz has announced the establishment of the Jason Mraz Foundation, devoted to supporting a number of charities for which he has been a dedicated and impassioned advocate

AVI Enters Into Collaborations for the Development of Two Additional Exon-Skipping Products for Duchenne Muscular Dystrophy (DMD)
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, today announced collaborations for the development of two additional exon-skipping drugs, one for exon 45 and one for exon 50, to support AVI's broad-based development program for the treatment of DMD. AVI's collaboration with Children's National Medical Center in Washington, D.C

UK govt. set to crackdown on Asian gangs who groom teenage girls for sex
The British government is finally planning to take measures to protect teenage girls who have been, or could be groomed, raped and sold by male gangs, most of whom are of Asian origin.

'High risk' of international spread of poliovirus from Pakistan: WHO
The risk of a deadly strain of poliovirus spreading from Pakistan is high, particularly given the large-scale population movements associated with Umrah and the upcoming Hajj (pilgrimage to Mecca, Kingdom of Saudi Arabia) in the coming months, the World Health Organisation (WHO) has warned.

Novel drug slows progression of Lou Gehrig's disease, cuts mortality
A novel drug dexpramipexole may help slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS), a new study has suggested.

Commonly used supplement might help recover from spinal cord injury
A team, including an Indian-origin researcher, has found that a commonly used supplement might improve outcomes and recovery for individuals who sustain a spinal cord injury (SCI).

Gene mutation linked to juvenile ALS identified
Scientists have discovered a gene mutation that may be linked to the development of juvenile amyotrophic lateral sclerosis (ALS), also referred to as Lou Gehrig's disease.

Students, psychiatric patients more prone to sleep paralysis
Students and psychiatric patients are more vulnerable to develop sleep paralysis, a new study has revealed.

IDBI Federal Launches Insured Wealth Plan
Private life insurer IDBI Federal Life Insurance today announced the launch of its new ULIP called Wealthsurance® Dreambuilder Insurance Plan which will enable customers to save and build wealth under the protective cover of insurance. Wealthsurance® combines wealth creation and insurance protection into one powerful financial solution

Comment on this story

Share